Skip to main content
Top
Published in: Updates in Surgery 3/2017

01-09-2017 | Review Article

Breast cancer in young women: an overview

Authors: Zoi Anastasiadi, Georgios D. Lianos, Eleftheria Ignatiadou, Haralampos V. Harissis, Michail Mitsis

Published in: Updates in Surgery | Issue 3/2017

Login to get access

Abstract

Despite dramatic advances in cancer research setting, breast cancer remains a major health problem and represents currently a top biomedical research priority. Worldwide, breast cancer is the most common cancer affecting women, and its incidence and mortality rates are expected to increase significantly the next years. Recently the researchers’ interest has been attracted by breast cancer arising in young women. Current evidence suggests that in women aged <45 years, breast cancer is unquestionably the leading cause of cancer-related deaths. This type of cancer seems to be highly heterogeneous and has potentially aggressive and complex biological features. However, management strategies, recommendations and options are not age based and the ‘complex’ biology of this type of cancer remains uncertain and unexplored. In this review, we summarize the latest scientific information on breast cancer arising in young women highlighting the heterogeneity and the complex nature of this type of cancer.
Literature
1.
go back to reference DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62CrossRefPubMed DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62CrossRefPubMed
2.
go back to reference DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Bio-markers Prev 20:733–749CrossRef DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Bio-markers Prev 20:733–749CrossRef
3.
go back to reference Greaney ML, Sprunck-Harrild K, Ruddy KJ et al (2015) Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. BMC Public Health 31(15):37CrossRef Greaney ML, Sprunck-Harrild K, Ruddy KJ et al (2015) Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. BMC Public Health 31(15):37CrossRef
5.
6.
8.
go back to reference Reyna C, Lee MC (2014) Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc 29(7):419–429 Reyna C, Lee MC (2014) Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc 29(7):419–429
9.
go back to reference Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478CrossRefPubMedPubMedCentral Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478CrossRefPubMedPubMedCentral
10.
12.
go back to reference Lianos GD, Vlachos K, Zoras O (2014) Potential of antibody-drug conjugates and novel therapeutics in breast cancer management. Onco Targets Ther 24(7):491–500 Lianos GD, Vlachos K, Zoras O (2014) Potential of antibody-drug conjugates and novel therapeutics in breast cancer management. Onco Targets Ther 24(7):491–500
13.
go back to reference Lianos GD, Roukos DH (2014) From linear ‘dogma’ and trastuzumab-emtansine to future transcriptional circuitry-based drug discovery for breast cancer. Future Oncol 10(2):145–148CrossRefPubMed Lianos GD, Roukos DH (2014) From linear ‘dogma’ and trastuzumab-emtansine to future transcriptional circuitry-based drug discovery for breast cancer. Future Oncol 10(2):145–148CrossRefPubMed
16.
go back to reference Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330CrossRefPubMed Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330CrossRefPubMed
17.
go back to reference Jankowsk M (2013) Sexual functioning in young women in the context of breast cancer treatment. Rep Pract Oncol Radiother 18(4):193–200CrossRef Jankowsk M (2013) Sexual functioning in young women in the context of breast cancer treatment. Rep Pract Oncol Radiother 18(4):193–200CrossRef
18.
go back to reference Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK et al (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82CrossRefPubMedPubMedCentral Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK et al (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82CrossRefPubMedPubMedCentral
19.
go back to reference Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-De-More N et al (2011) Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29:e18–e20CrossRefPubMed Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-De-More N et al (2011) Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29:e18–e20CrossRefPubMed
20.
go back to reference Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77:97–103CrossRefPubMed Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77:97–103CrossRefPubMed
21.
go back to reference Kim HJ, Han W, Yi OV, Shin HC, Ahn SK, Koh BS et al (2011) Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype. Breast Cancer Res Treat 130:499–505CrossRefPubMed Kim HJ, Han W, Yi OV, Shin HC, Ahn SK, Koh BS et al (2011) Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype. Breast Cancer Res Treat 130:499–505CrossRefPubMed
22.
go back to reference Vitale SG, Valenti G, Gulino FA, Cignini P, Biondi A (2016) Surgical treatment of high stage endometrial cancer: current perspectives. Updates Surg 68(2):149–154CrossRefPubMed Vitale SG, Valenti G, Gulino FA, Cignini P, Biondi A (2016) Surgical treatment of high stage endometrial cancer: current perspectives. Updates Surg 68(2):149–154CrossRefPubMed
23.
go back to reference Rossetti D, Vitale SG, Gulino FA, Cignini P, Rapisarda AMC, Biondi A, Frigerio L (2016) Concomitant chemoradiation treatment in selected stage I endometrioid endometrial cancers. Eur J Gynaecol Oncol 37(5):657–661 Rossetti D, Vitale SG, Gulino FA, Cignini P, Rapisarda AMC, Biondi A, Frigerio L (2016) Concomitant chemoradiation treatment in selected stage I endometrioid endometrial cancers. Eur J Gynaecol Oncol 37(5):657–661
24.
go back to reference Woodson AH, Profato JL, Muse KI, Litton JK et al (2013) Breast cancer in the young: role of the geneticist. J Thorac Dis 5(Suppl 1):S19–S26PubMedPubMedCentral Woodson AH, Profato JL, Muse KI, Litton JK et al (2013) Breast cancer in the young: role of the geneticist. J Thorac Dis 5(Suppl 1):S19–S26PubMedPubMedCentral
25.
go back to reference Desmedt C, Yates L, Kulka J et al (2016) Catalog of genetic progression of human cancers: breast cancer. Cancer Metastasis Rev 35(1):49–62PubMed Desmedt C, Yates L, Kulka J et al (2016) Catalog of genetic progression of human cancers: breast cancer. Cancer Metastasis Rev 35(1):49–62PubMed
26.
go back to reference Weisman PS, Ng CK, Brogi E et al (2016) Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Mod Pathol 29(5):476–488CrossRefPubMedPubMedCentral Weisman PS, Ng CK, Brogi E et al (2016) Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Mod Pathol 29(5):476–488CrossRefPubMedPubMedCentral
28.
go back to reference Stephens PJ, Tarpey PS, Davies H et al (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486(7403):400–404PubMedPubMedCentral Stephens PJ, Tarpey PS, Davies H et al (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486(7403):400–404PubMedPubMedCentral
29.
go back to reference Azim HA Jr, Brohee S, Peccatori FA et al (2014) Biology of breast cancer during pregnancy using genomic profiling. Endocr Relat Cancer 21:545–554CrossRefPubMed Azim HA Jr, Brohee S, Peccatori FA et al (2014) Biology of breast cancer during pregnancy using genomic profiling. Endocr Relat Cancer 21:545–554CrossRefPubMed
30.
go back to reference Shuen AY, Foulkes WD (2011) Inherited mutations in breast cancer genes—risk and response. J Mamm Gland Biol Neoplasia 16:3–15CrossRef Shuen AY, Foulkes WD (2011) Inherited mutations in breast cancer genes—risk and response. J Mamm Gland Biol Neoplasia 16:3–15CrossRef
31.
go back to reference Huzarski T, Byrski T, Gronwald J et al (2013) Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. J Clin Oncol 31:3191–3196CrossRefPubMed Huzarski T, Byrski T, Gronwald J et al (2013) Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. J Clin Oncol 31:3191–3196CrossRefPubMed
32.
go back to reference Weischer M, Nordestgaard BG, Pharoah P et al (2012) CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30:4308–4316CrossRefPubMedPubMedCentral Weischer M, Nordestgaard BG, Pharoah P et al (2012) CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30:4308–4316CrossRefPubMedPubMedCentral
33.
go back to reference Lianos GD, Zoras O, Roukos DH (2013) Beyond BRCA1/2: polygenic, ‘polyfunctional’ molecular circuitry model to predict breast cancer risk. Biomark Med 7(5):675–678CrossRefPubMed Lianos GD, Zoras O, Roukos DH (2013) Beyond BRCA1/2: polygenic, ‘polyfunctional’ molecular circuitry model to predict breast cancer risk. Biomark Med 7(5):675–678CrossRefPubMed
34.
go back to reference Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D (2013) POSH Study Steering Group: prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study. J Natl Cancer Inst 105:978–988CrossRefPubMed Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D (2013) POSH Study Steering Group: prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study. J Natl Cancer Inst 105:978–988CrossRefPubMed
35.
go back to reference Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131:1061–1066CrossRefPubMed Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131:1061–1066CrossRefPubMed
36.
go back to reference Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA (2009) Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208:341–347CrossRefPubMedPubMedCentral Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA (2009) Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208:341–347CrossRefPubMedPubMedCentral
37.
go back to reference Keegan TH, DeRouen MC, Press DJ, Kurian AW, Clarke CA (2012) Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res 14:R55CrossRefPubMedPubMedCentral Keegan TH, DeRouen MC, Press DJ, Kurian AW, Clarke CA (2012) Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res 14:R55CrossRefPubMedPubMedCentral
38.
go back to reference Azim HA Jr, Nguyen B, Brohée S et al (2015) Genomic aberrations in young and elderly breast cancer patients. BMC Med 15(13):266CrossRef Azim HA Jr, Nguyen B, Brohée S et al (2015) Genomic aberrations in young and elderly breast cancer patients. BMC Med 15(13):266CrossRef
39.
go back to reference Azim H, Azim HA Jr (2013) Targeting RANKL in breast cancer: bone metastasis and beyond. Expert Rev Anticancer Ther 13:195–201CrossRefPubMed Azim H, Azim HA Jr (2013) Targeting RANKL in breast cancer: bone metastasis and beyond. Expert Rev Anticancer Ther 13:195–201CrossRefPubMed
40.
go back to reference Ribnikar D, Ribeiro JM, Pinto D et al (2015) Breast cancer under age 40: a different approach. Curr Treat Options Oncol 16(4):16CrossRefPubMed Ribnikar D, Ribeiro JM, Pinto D et al (2015) Breast cancer under age 40: a different approach. Curr Treat Options Oncol 16(4):16CrossRefPubMed
41.
go back to reference Ademuyiwa FO, Cyr A, Ivanovich J, Thomas MA (2015) Managing breast cancer in younger women: challenges and solutions. Breast Cancer (Dove Med Press) 21(8):1–12 Ademuyiwa FO, Cyr A, Ivanovich J, Thomas MA (2015) Managing breast cancer in younger women: challenges and solutions. Breast Cancer (Dove Med Press) 21(8):1–12
42.
go back to reference Bellia A, Vitale SG, Laganà AS et al (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294(3):615–622CrossRefPubMed Bellia A, Vitale SG, Laganà AS et al (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294(3):615–622CrossRefPubMed
43.
go back to reference Vitale SG, Valenti G, Biondi A, Rossetti D, Frigerio L (2015) Recent trends in surgical and reconstructive management of vulvar cancer: review of literature. Updates Surg 67(4):367–371CrossRefPubMed Vitale SG, Valenti G, Biondi A, Rossetti D, Frigerio L (2015) Recent trends in surgical and reconstructive management of vulvar cancer: review of literature. Updates Surg 67(4):367–371CrossRefPubMed
46.
go back to reference Verigos J, Magklara A (2015) Revealing the complexity of breast cancer by next generation sequencing. Cancers (Basel) 7(4):2183–2200CrossRef Verigos J, Magklara A (2015) Revealing the complexity of breast cancer by next generation sequencing. Cancers (Basel) 7(4):2183–2200CrossRef
47.
48.
go back to reference Desmedt C, Voet T, Sotiriou C, Campbell PJ (2012) Next-generation sequencing in breast cancer: first take home messages. Curr Opin Oncol 24(6):597–604CrossRefPubMedPubMedCentral Desmedt C, Voet T, Sotiriou C, Campbell PJ (2012) Next-generation sequencing in breast cancer: first take home messages. Curr Opin Oncol 24(6):597–604CrossRefPubMedPubMedCentral
49.
go back to reference Rosa M (2015) Advances in the molecular analysis of breast cancer: pathway toward personalized medicine. Cancer Control 22(2):211–219CrossRefPubMed Rosa M (2015) Advances in the molecular analysis of breast cancer: pathway toward personalized medicine. Cancer Control 22(2):211–219CrossRefPubMed
50.
go back to reference Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48CrossRefPubMed Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48CrossRefPubMed
Metadata
Title
Breast cancer in young women: an overview
Authors
Zoi Anastasiadi
Georgios D. Lianos
Eleftheria Ignatiadou
Haralampos V. Harissis
Michail Mitsis
Publication date
01-09-2017
Publisher
Springer Milan
Published in
Updates in Surgery / Issue 3/2017
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-017-0424-1

Other articles of this Issue 3/2017

Updates in Surgery 3/2017 Go to the issue